IRIS
CICONTE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.945
AS - Asia 1.910
EU - Europa 1.902
SA - Sud America 490
Continente sconosciuto - Info sul continente non disponibili 237
AF - Africa 55
Totale 6.539
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.820
RU - Federazione Russa 1.113
SG - Singapore 719
CN - Cina 529
BR - Brasile 394
IT - Italia 238
HK - Hong Kong 227
VN - Vietnam 194
SE - Svezia 165
FR - Francia 81
DE - Germania 80
CA - Canada 56
GB - Regno Unito 52
BD - Bangladesh 47
FI - Finlandia 46
IN - India 39
AR - Argentina 34
MX - Messico 28
IE - Irlanda 24
ID - Indonesia 22
JP - Giappone 21
NL - Olanda 20
AT - Austria 19
ZA - Sudafrica 19
PL - Polonia 18
EC - Ecuador 15
TR - Turchia 15
CO - Colombia 14
IQ - Iraq 13
PK - Pakistan 12
LT - Lituania 11
MA - Marocco 9
PY - Paraguay 9
CR - Costa Rica 8
ES - Italia 8
JM - Giamaica 8
KE - Kenya 8
OM - Oman 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
CL - Cile 7
MD - Moldavia 7
VE - Venezuela 7
PH - Filippine 6
EG - Egitto 5
NP - Nepal 5
DO - Repubblica Dominicana 4
HN - Honduras 4
IR - Iran 4
JO - Giordania 4
MY - Malesia 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UA - Ucraina 3
BB - Barbados 2
DZ - Algeria 2
GT - Guatemala 2
KZ - Kazakistan 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GP - Guadalupe 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
PR - Porto Rico 1
RO - Romania 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TL - Timor Orientale 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 6.305
Salva come PNG Salva come JPEG
Città #
Singapore 309
Moscow 230
Hong Kong 226
Ashburn 224
San Jose 196
Dallas 182
Council Bluffs 161
Shanghai 99
Hefei 83
Milan 73
Beijing 71
Ho Chi Minh City 71
Lauterbourg 70
Lawrence 64
Princeton 62
Santa Clara 60
New York 57
Los Angeles 36
Hanoi 35
São Paulo 34
Helsinki 32
Orem 28
Dublin 23
London 20
Rome 19
Nuremberg 17
Tokyo 17
Brooklyn 16
Chennai 16
Toronto 16
Warsaw 16
Denver 15
Montreal 15
Phoenix 15
Frankfurt am Main 14
Boardman 13
Amsterdam 12
Atlanta 12
San Francisco 12
Vienna 12
Cesano Boscone 11
Haiphong 11
Seattle 11
Chicago 10
Mexico City 10
Rio de Janeiro 10
Biên Hòa 9
Brasília 9
Johannesburg 9
Las Vegas 9
Munich 8
Stockholm 8
Ankara 7
Brescia 7
Falkenstein 7
Manchester 7
Nairobi 7
Omaha 7
Turku 7
Belo Horizonte 6
Buenos Aires 6
Curitiba 6
Guangzhou 6
Lappeenranta 6
Muscat 6
Naples 6
Queens 6
Quito 6
Recife 6
Salvador 6
San José 6
Asunción 5
Da Nang 5
Ferrara 5
Goiânia 5
Guarulhos 5
Hangzhou 5
Houston 5
Jakarta 5
Kassel 5
Memphis 5
Mumbai 5
Philadelphia 5
Poplar 5
Santiago 5
The Bronx 5
The Dalles 5
Thái Nguyên 5
Viareggio 5
Wolfhagen 5
Amman 4
Aracaju 4
Bellmore 4
Boston 4
Brussels 4
Casablanca 4
Charlotte 4
City of London 4
Dhaka 4
Ha Long 4
Totale 3.054
Salva come PNG Salva come JPEG
Nome #
Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients 260
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 147
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 141
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 132
Brugada syndrome genetics is associated with phenotype severity 125
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 122
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 117
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 114
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 112
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 112
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 111
Brugada Syndrome: Warning of a Systemic Condition? 109
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 108
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 103
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 99
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 99
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 98
HIF-1α Directly Controls WNT7A Expression During Myogenesis 98
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 97
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 90
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique 90
Brugada Syndrome: Oligogenic or Mendelian Disease? 87
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 84
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 80
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 80
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 80
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 79
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 78
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 76
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 75
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 75
Atrial fibrillation progression and management: a 5-year prospective follow-up study 75
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 75
Regenerating the human heart : direct reprogramming strategies and their current limitations 73
Deep learning unmasks the ECG signature of Brugada syndrome 72
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 71
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 71
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 70
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 70
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 69
General Anesthesia Attenuates Brugada Syndrome Phenotype Expression: Clinical Implications From a Prospective Clinical Trial 67
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 66
Congenital coronary artery anomalies: Differential diagnosis of ventricular arrhythmias in young athletes 66
Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene 65
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 65
Epicardial arrhythmogenic substrate in long QT syndrome 64
Long-term outcome of remote catheter ablation using a magnetic irrigated-tip catheter 64
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 62
Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry 61
The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children 60
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 59
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Prevalence and clinical significance 58
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 57
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 57
Thrombosis on a left atrial appendage occluder device: The double-edged sword of stroke prevention strategies in atrial fibrillation 57
Atrial Fibrillation Progression in Patients With and Without Lone Atrial Fibrillation: A Five-Year Prospective Follow-Up Study 56
Unusual response to ajmaline test in Brugada syndrome patient leads to extracorporeal membrane oxygenator support 56
AF ablation in the elderly population. The Milan experience 55
Safety and efficacy of circumferential pulmonary vein ablation in octogenarians with atrial fibrillation 55
Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies 55
Remote irrigated-tip ablation. The first human experience in patients with WPW syndrome 54
Safety and feasibility of a novel multielectrode array catheter in mapping atrial and ventricular arrhythmias with high density: results from the multicenter OPTIMUM study 53
The natural history of ventricular preexcitation in 293 asymptomatic adult subjects 52
The role of implantable cardiac monitors in atrial fibrillation management 52
Novel CineECG Derived from Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients with Brugada Syndrome 52
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation 52
Long-term outcome benefits of catheter ablation versus antiarrhythmic drug therapy. A prospective, randomized two year extension study, the APAF 2 Study 51
Early rhythm control strategy by catheter ablation in patients with paroxysmal atrial fibrillation: the 4-year results of a randomized follow-up study comparing catheter ablation and antiarrhythmic drug therapy: The APAF 2 Study 51
New-Onset Atrial Fibrillation as the First Clinical Manifestation of Latent Brugada Syndrome: Incidence and Clinical Significance 50
Reversine: A Synthetic Purine with a Dual Activity as a Cell Dedifferentiating Agent and a Selective Anticancer Drug 49
Catheter ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. A Long-term Randomized Follow-up Study. The APAF2 Study 48
First human experience with an irrigated tip catheter for remote circumferential pulmonary vein ablation. Preliminary results in 33 patients with atrial fibrillation 48
Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy? 47
Circumferential Pulmonary Vein Ablation Using a Remote Irrigated Tip Magnetic Catheter: Long-Term Outcome 47
Lone atrial fibrillation as the first clinical manifestation of a latent Brugada syndrome 46
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value 45
Non-paroxysmal atrial fibrillation mapping: characterization of the electrophysiological substrate using a novel integrated mapping technique 45
Catheter ablation versus antiarrhythmic drug therapy. A prospective, randomized, long-term study. The APAF 2 44
Predictors of sudden death in patients with Wolff-Parkinson-White Syndrome. A prospective follow-up study of 201 symptomatic WPW patients presenting with malignant arrhythmias 42
Safety, Efficacy and Follow-Up of Circumferential Pulmonary Vein Ablation in Octogenarians 41
The First Human Experience With An Irrigated-tip Magnetic Catheter In Patients Undergoing Remote Ablation Of Atrial Fibrillation 41
Epicardial ablation in genetic cardiomyopathies: A new frontier 41
The “arrhythmic” presentation of peripartum cardiomyopathy: case series and critical review of the literature 15
Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death 14
Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation 13
High-risk Brugada syndrome: Factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation 12
Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective study 11
Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: A single-center study in a large cohort of patients 9
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 9
Left bundle branch area pacing vs. right ventricular pacing in post-transcatheter aortic valve implantation patients: a retrospective propensity-matched analysis 9
Atrial fibrillation laser balloon ablation: Multicenter international study 9
Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy 9
Structural characterization of atrial natriuretic peptide amyloid fibrils from patients with atrial fibrillation 8
Ablation of ventricular arrhythmias in cardiogenetic diseases 8
The clinical impact of ajmaline challenge in elderly patients with suspected atrioventricular conduction disease 7
Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study 7
Pulmonary vein isolation in patients with Brugada syndrome and atrial fibrillation: a 2-year follow-up 7
Beta-Blockers after Myocardial Infarction 7
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation 7
Win or tie? Rethinking anticoagulation in device-detected AF 7
Totale 6.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 13 4 2 15 1 6 0 0 1
2022/2023360 160 68 19 7 2 41 22 13 21 5 2 0
2023/2024155 2 4 14 44 12 14 5 15 0 6 13 26
2024/20251.239 174 47 7 34 58 88 150 132 208 154 74 113
2025/20263.939 237 304 299 572 290 101 324 250 1.016 220 194 132
2026/2027737 341 396 0 0 0 0 0 0 0 0 0 0
Totale 6.539